BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.580
-0.030 (-1.86%)
At close: Dec 5, 2025, 4:00 PM EST
1.520
-0.060 (-3.80%)
After-hours: Dec 5, 2025, 4:40 PM EST
BioVie Employees
BioVie had 13 employees as of June 30, 2025. The number of employees decreased by 1 or -7.14% compared to the previous year.
Employees
13
Change (1Y)
-1
Growth (1Y)
-7.14%
Revenue / Employee
n/a
Profits / Employee
-$1,428,124
Market Cap
11.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BIVI News
- 17 days ago - Join Biovie's Exclusive Live Investor Webinar and Q&A Session on December 9 - GlobeNewsWire
- 6 weeks ago - Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 2 months ago - BioVie Inc. - Special Call - Seeking Alpha
- 2 months ago - BioVie to Host Live Investor Webinar and Q&A on Oct. 8 - GlobeNewsWire
- 4 months ago - BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes - GlobeNewsWire
- 4 months ago - BioVie Inc. Announces Pricing of $12 Million Public Offering - GlobeNewsWire
- 4 months ago - BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology - GlobeNewsWire
- 4 months ago - BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors - GlobeNewsWire